Daniel D. Von Hoff, MD, FAACR
AACR Distinguished Public Service Award

Daniel D. Von Hoff, MD, FAACR

Physician in Chief
Clinical Research
The Translational Genomics Research Institute
Phoenix, Arizona

For his extraordinary clinical research career and leadership in establishing the AACR/ASCO Methods in Clinical Cancer Research Workshop to educate and train young clinical investigators.

An internationally recognized physician-scientist, innovator, and expert in the development of anticancer therapies, Von Hoff has helped develop many approved therapeutic agents including, but not limited to dexrazoxane, docetaxel, fludarabine, gemcitabine, irinotecan, mitoxantrone, nab-paclitaxel, paclitaxel, topotecan, and vismodegib.